Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, 314001, China.
Jiaxing Key Laboratory for Minimally Invasive Surgery in Orthopaedics & Skeletal Regenerative Medicine, Zhejiang Rongjun Hospital, Jiaxing, China.
QJM. 2022 Jan 21;115(1):12-16. doi: 10.1093/qjmed/hcaa278.
BACKGROUND/INTRODUCTION: Knee joint osteoarthritis is a chronic disease that affects the health in aging population.
We explore a minimally invasive surgery combining the use of ultrasonic drug penetration to treat early stage of knee joint osteoarthritis.
In total, 75 patients were participated in acupotomy therapy and ultrasonic drug penetration to treat joint osteoarthritis.
The WOMAC (the Western Ontario and McMaster Universities Osteoarthritis Index) scores were used to assess the performance.
There was a significant difference in the WOMAC score between the two groups of patients (P < 0.05). The total performance rate was about 86.4% and 50% in experiment and control groups.
The combination of acupotomy therapy and ultrasonic drug penetration has demonstrated to be effective and promising to treat knee joint osteoarthritis.
背景/引言：膝关节骨关节炎是一种影响老龄化人口健康的慢性疾病。
我们探索一种微创手术，结合超声药物渗透技术来治疗膝关节骨关节炎的早期阶段。
共有 75 例患者接受针刀疗法和超声药物渗透治疗关节骨关节炎。
采用西部安大略省和麦克马斯特大学骨关节炎指数（WOMAC）评分来评估疗效。
两组患者的 WOMAC 评分有显著差异（P<0.05）。实验组和对照组的总有效率分别约为 86.4%和 50%。
针刀疗法联合超声药物渗透治疗膝关节骨关节炎具有疗效好、前景好的特点。
